- Molecular cytogenetic studies of complex karyotypes in myelodysplastic syndromes (MDS): conventional cytogenetics, FISH and multiplex FISH (mFISH/mBAND)Publication without faculty affiliation
- True monozomy of chromosome 5 is presumably not an isolated cytogenetic entity in myelodysplastic syndromes (MDS).Publication without faculty affiliation
- Proapoptotic activity of T-cells in myelodysplastic syndromes (MDS)2001 | Second Faculty of Medicine
- The International Prognostic Scoring System (IPSS) for childhood myelodysplastic syndrome (MDS) and juvenile myelomonocytic leukemia (JMML)2004 | Second Faculty of Medicine
- New therapeutic approaches and perspectives in the treatment of myelodysplastic syndrome2019 | First Faculty of Medicine
- Retrospective study of deletions of 5q in patients with myelodysplastic syndrome (MDS) or acute maeloid leukemia (AML)Publication without faculty affiliation
- Significance of deletion del(5)(q31) and complex chromosomal rearrangements in patients with myelodysplastic syndrome (MDS)Publication without faculty affiliation
- Dynamics of telomere length and its association with genome instability in myelodysplastic syndromes (MDS) and acute myelogenous leukemia arising from MDSPublication without faculty affiliation
- Heterogenity of telomere lenght and telomerase activity in myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) and their prognostic value for leukemic transformationPublication without faculty affiliation
- Maping of breakpoints in patients with MDS and complex karyotype by microarray methodPublication without faculty affiliation
- Involvement of deleted chromosome 5 in complex chromosomal aberrations in newly diagnosed myelodysplastic syndromes (MDS) is correlated with extremely adverse prognosis2014 | First Faculty of Medicine
- MiRNA expression profilig in 5q-syndrome patiens treated with lenalidomidePublication without faculty affiliation
- Treatment of Chronic Myelomonocytic Leukemia with 5-Azacytidine: Case Reports2012 | First Faculty of Medicine
- Prognostic significance of deletion del(5)(q31) and complex chromosomal rearrangements in patients with myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML)ePublication without faculty affiliation
- Dynamics of telomerw erosion and its association with genome instability in myelodysplastic syndromes (MDS) and acute myelogenous leukemi arising from MDS: a marker of disease prognosis?2004 | First Faculty of Medicine
- Dynamics of telomerw erosion and its association with genome instability in myelodysplastic syndromes (MDS) and acute myelogenous leukemi arising from MDS: a marker of disease prognosis?2004 | Faculty of Physical Education and Sport
- Myelodysplastic syndrome, juvenile myelomonocytic leukemia, and acute myeloid leukemia associated with complete or partial monosomy 71999 | Second Faculty of Medicine
- Deferasirox in patients with myelodysplastic syndrome and iron overload - Results of the EPIC study - Commenting on the study2013 | First Faculty of Medicine
- Current options for biological treatment in patients with myelodysplastic syndrom2022 | First Faculty of Medicine
- The response of FLi1, EKLF, TP53 (p53), PU.1, MDM2 gene expression in 5q- syndrome to lenalidomide treatmentPublication without faculty affiliation
- Applicability of a reproducible flow cytometry scoring system in the diagnosis of refractory cytopenia of childhood2013 | Second Faculty of Medicine
- Melodysplastic syndrome2016 | Faculty of Medicine in Hradec Králové
- Commentary on a study2011 | Publication without faculty affiliation
- Research Report University Hospital for clinical assessment 20090160Publication without faculty affiliation
- Czech MDS Group experience with azacitidine in treatment of high risk MDS and AML patientsPublication without faculty affiliation
- Experiences with chelation therapy in myelodysplastic syndrome.2009 | Publication without faculty affiliation
- Combination of molecular cytogenetic techniques in mapping of the atypical 5q deletion in myeloid malignanciesPublication without faculty affiliation
- Are we justified to classify patients with two unrelated clones with del(5q) and trisomy 8 as a subgroup of myelodysplastic syndrome of the type of 5q-syndrome?2014 | First Faculty of Medicine
- The clinical relevance of minor paroxysmal nocturnal hemoglobinuria clones in refractory cytopenia of childhood: a prospective study by EWOG-MDS2014 | Second Faculty of Medicine
- Current recommendations in chelation therapy2013 | First Faculty of Medicine